Premium
Phosphorylation of cyclic AMP‐response element–binding protein (CREB) is influenced by melatonin treatment in pancreatic rat insulinoma β‐cells (INS‐1)
Author(s) -
BazwinskyWutschke Ivonne,
Wolgast Sabine,
Mühlbauer Eckhard,
Albrecht Elke,
Peschke Elmar
Publication year - 2012
Publication title -
journal of pineal research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 131
eISSN - 1600-079X
pISSN - 0742-3098
DOI - 10.1111/j.1600-079x.2012.01004.x
Subject(s) - creb , ibmx , melatonin , medicine , endocrinology , melatonin receptor , forskolin , biology , receptor , luzindole , insulinoma , chemistry , transcription factor , insulin , biochemistry , gene
The pineal hormone melatonin exerts its influence on the insulin secretion of pancreatic islets by a variety of signalling pathways. The purpose of the present study was to analyse the impact of melatonin on the phosphorylated transcription factor cAMP‐response element–binding protein (pCREB). In pancreatic rat insulinoma β‐cells (INS‐1), pCREB immunofluorescence intensities in cell nuclei using digitised confocal image analysis were measured to semi‐quantify differences in the pCREB immunoreactivity (pCREB‐ir) caused by different treatments. Increasing concentrations of forskolin or 3‐isobutyl‐1‐methylxanthine (IBMX) resulted in a dose‐dependent rise of the mean fluorescence intensity in pCREB‐ir nuclear staining. Concomitant melatonin application significantly decreased pCREB‐ir in INS‐1 cells after 30‐min, 1‐hr and 3‐hr treatment. The melatonin receptor antagonists luzindole and 4‐phenyl‐2‐propionamidotetraline (4P‐PDOT) completely abolished the pCREB phosphorylation–decreasing effect of melatonin, indicating that both melatonin receptor isoforms (MT 1 and MT 2 ) are involved. In a transfected INS‐1 cell line expressing the human MT 2 receptor, melatonin caused the greatest reduction in pCREB after IBMX treatment compared with nontransfected INS‐1 cells, indicating a crucial influence of melatonin receptor density on pCREB regulation. Furthermore, the downregulation of pCREB by melatonin is concomitantly associated with a statistically significant downregulation of Camk2d transcript levels, as measured after 3 hr. In conclusion, the present study provides evidence that the phosphorylation level of CREB is modulated in pancreatic β‐cells by melatonin. Mediated via CREB, melatonin regulates the expression of genes that play an important functional role in the regulation of β‐cell signalling pathways.